1. Home
  2. LEE vs ASRT Comparison

LEE vs ASRT Comparison

Compare LEE & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • ASRT
  • Stock Information
  • Founded
  • LEE 1890
  • ASRT 1995
  • Country
  • LEE United States
  • ASRT United States
  • Employees
  • LEE N/A
  • ASRT N/A
  • Industry
  • LEE Newspapers/Magazines
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • ASRT Health Care
  • Exchange
  • LEE Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • LEE 90.6M
  • ASRT 85.1M
  • IPO Year
  • LEE N/A
  • ASRT 1997
  • Fundamental
  • Price
  • LEE $12.20
  • ASRT $0.80
  • Analyst Decision
  • LEE
  • ASRT Strong Buy
  • Analyst Count
  • LEE 0
  • ASRT 4
  • Target Price
  • LEE N/A
  • ASRT $3.19
  • AVG Volume (30 Days)
  • LEE 30.5K
  • ASRT 357.9K
  • Earning Date
  • LEE 02-06-2025
  • ASRT 03-10-2025
  • Dividend Yield
  • LEE N/A
  • ASRT N/A
  • EPS Growth
  • LEE N/A
  • ASRT N/A
  • EPS
  • LEE N/A
  • ASRT N/A
  • Revenue
  • LEE $600,264,000.00
  • ASRT $125,763,000.00
  • Revenue This Year
  • LEE N/A
  • ASRT N/A
  • Revenue Next Year
  • LEE N/A
  • ASRT $1.84
  • P/E Ratio
  • LEE N/A
  • ASRT N/A
  • Revenue Growth
  • LEE N/A
  • ASRT N/A
  • 52 Week Low
  • LEE $7.57
  • ASRT $0.73
  • 52 Week High
  • LEE $19.63
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • LEE 36.69
  • ASRT 43.92
  • Support Level
  • LEE $11.87
  • ASRT $0.78
  • Resistance Level
  • LEE $13.69
  • ASRT $0.83
  • Average True Range (ATR)
  • LEE 0.92
  • ASRT 0.03
  • MACD
  • LEE 0.01
  • ASRT 0.00
  • Stochastic Oscillator
  • LEE 19.18
  • ASRT 39.86

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: